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hypothyroidism; hyt mouse; TSH receptor; chondrocyte; growth plate CONGENITAL HYPOTHYROIDISM (CH) is a condition caused by an in utero or neonatal deficiency of thyroid hormones. Left untreated, thyroid hormone deficiency leads to reduced somatic growth and reduced linear bone growth, and epiphysial dysgenesis is commonly observed in affected young children (5, 18, 25) .
Thyroid hormone actions are initiated by an interaction of triiodothyronine (T 3 ) with thyroid hormone receptors (TR) TR␣1 and TR␤1. Recent studies have revealed that both receptors are expressed in the growth plate, bone marrow stromal cells, and osteoblasts (8, 27) and that TR␣ is expressed at substantially higher levels than TR␤ in bone, suggesting that the skeleton may be a predominantly TR␣-responsive T 3 target tissue (7, 23) . These regulatory effects of thyroid hormone on growth rate via TR␣ might interact with key signaling pathways that control chondrocyte differentiation, including growth hormone (GH) and insulin-like growth factor I (4, 21) . Despite the pivotal role of thyroid hormone in skeletal development, most cases of CH are invariably accompanied by increased secretion of TSH in a normal negative feedback mechanism. However, roles of high TSH in the pathogenesis of epiphysial dysgenesis remain unknown.
The C.RF-Tshr hyt/hyt (hyt/hyt) mouse is an animal model of hypothyroidism resulting from mutation in the fourth transmembrane domain of the thyroid-stimulating hormone receptor (TSHR). A proline to leucine mutation at codon 556 results in plasma membrane targeting, but defective TSH binding and defective receptor function without altering TSHR expression (12, 29) .
During breeding of the hyt/hyt mice (11), we noticed that adult hyt/hyt mice were indistinguishable from wild-type mice by their size, leading us to study the roles of TSH in the pathogenesis of growth retardation in young mice with hypothyroidism. (hyt/wild) (strain name: CBy.RF-Tshr hyt /J) mice were obtained from Jackson Laboratory (Bar Harbor, ME). The mice were bred to generate experimental animals. The mice did not receive any thyroid hormone supplementation until the experiment. Even without treatment, both sexes of hyt/wild mice and male hyt/hyt mice were fertile. Hyt mice were born healthy and developed normally except for being slightly shorter than wild-type mice. To maintain hyt/hyt mice in the euthyroid state, we started to breed animals with food pellets containing various amounts of thyroid extract from the beginning of the experiment (25 days old). We determined that 125 ppm of Thyradine powder (Asuka Pharmaceutical, Tokyo, Japan) resulted in maintenance of the euthyroid state. Genotyping of mice was carried out by direct sequencing at 19 days after birth. Thyroidectomy and sham operation (median incision of the neck, exposure of trachea and suturing of the skin) was carried out 21 days after birth. Primary cultured mouse epiphysial chondrocytes were isolated from femoral head cartilage. Femoral heads from 3-wk-old mice were obtained by the methods of Stanton et al. (28) . Chondrocytes were released from the heads by digesting with 5 mg/ml pronase (Roche Diagnostics, Tokyo, Japan) at 37°C for 30 min followed by digestion with 2 mg/ml collagenase (type II; Sigma-Aldrich, St. Louis, MO) at 37°C for 2 h (32). The cells were cultured in minimum essential medium (MEM) containing 10% fetal bovine serum. FRTL-5 (functional rat thyroid epithelial cells) and BRL-3 rat liver cells were cultured as described previously (10) .
MATERIALS AND METHODS

Animals and cells.
Quantitative PCR. Messenger RNAs from cultured cells and tissues were prepared by the RNeasy Mini Kit (QIAGEN, Valencia, CA). RNAs (2 g) were reverse transcribed with Rous-associated virus reverse transcriptase (Takara Bio, Shiga, Japan) at 37°C for 60 min in a 50-l mixture in the presence of a random primer. Quantitative PCR was carried out with Rotor-Gene Q (QIAGEN) using TaqMan probes (Applied Biosystems, Carlsbad, CA) for mouse TSHR (MA0042027_A1), mouse Sox-9 (Mm00448840_m1), mouse type IIa collagen (Mm01309565_ m1), mouse 18S ribosomal RNA (Mm03928990_g1), and mouse glyceral-dehyde-3-phosphate dehydrogenase (GAPDH; Mm999999_g1). Each assay was carried out in triplicate, and transcription levels were normalized using 18S RNA or GAPDH as reference gene. Expression of 18S RNA or GAPDH from the samples was within Ϯ 1.0 CT (cycle number of threshold) level.
Thyroid functions, measurement of hormones, and 125 I-TSH binding. Serum free T 3 and free thyroxine (T4) were assayed using the ECLusis system (Roche Diagnostic). Mouse TSH and GH were assayed using the ELISA kit from Shibayagi (Gunma, Japan). Serum Ca 2ϩ was measured using Aqua-auto Kainos Ca reagent (Kainos, Japan).
125 I-TSH binding activities of the cells were determined using the methods of Mizutori et al. (22) with 125 I-bovine TSH (Cosmic, Tokyo, Japan). Cyclic AMP in the cells was assayed using a commercially available RIA kit (Yamasa Shoyu, Chiba, Japan).
Immunohistochemistry for TSHR. For preparing sections, tibia was decalcified by Decalcifying Solution B (EDTA method; Wako Pure Chemicals Industries, Osaka, Japan). Sections were pretreated with Target Retrieval Solution, pH9 (Dako, Tokyo, Japan), at 100°C for 3 min. Immunohistochemistry for TSHR was carried out using rabbit polyclonal anti-TSHR antibody (HPA026680, 1:200, Sigma-Aldrich) with an ABC staining system (Santa Cruz Biotechnology, Santa Cruz, CA) as described previously (11) .
Statistical analysis. Statistical analysis was carried out by one-way ANOVA and Student's t-test. Figure 1A shows growth curves of the wild-type and hyt/hyt mice. Length (from tip of the nose to base of the tail) of hyt/hyt mice (n ϭ 5) was significantly shorter than that of the wild-type mice (n ϭ 5) during juvenile life (from 23 days to 9 wk old, P Ͻ 0.01), as described by Adams et al. (2) , but we observed that the length of adult hyt/hyt mice (14 wk old) was similar to that of the wild-type mice. hyt/hyt limbs at 14 wk old were only 6% shorter than those of wild-type littermates (Fig. 1A) despite the fact that their serum free T 4 was very low (Fig. 1C) . Serum T 4 levels of hyt/hyt mice were low throughout their life (2), yet these mice did not show dwarfism.
RESULTS
Length of young and adult hyt/hyt mice.
Expression of TSHR in chondrocytes. On the basis of these observations, we investigated whether epiphysial cartilage expressed TSHR or not. Quantitative RT-PCR demonstrated TSHR mRNA levels in all cartilage tissues, including the end of bone, were 42-70% of that in the thyroid. The end of bone sample presumably contains not only growth plate cartilage but also bone from the secondary ossification center. However, expression level of TSHR message in the end of bone was almost comparable to those from pure cartilage tissue such as auricular ( Fig. 2A) .
We then examined the expression of TSHR in chondrocytes by immunohistochemistry. Anti-TSHR antibody specifically stained thyroid epithelial cells (Fig. 2, B and C) , and the antibody also stained chondrocytes in the epiphysial cartilage of the tibia (Fig. 2, D and E) .
We obtained chondrocytes from femoral head cartilage for further studying whether chondrocytes express TSHR. In primary cultures of chondrocytes (cultured for 72 h), Alcian blue treatment resulted in staining of nearly all cells (Fig. 3A) . We studied 125 I-TSH binding activity and responsiveness of cultured chondrocytes to TSH. We observed high-affinity TSH binding activity on the cells (Fig. 3B) . TSH dose-dependently increased cAMP production in cultured chondrocytes (Fig.  3C) . These results also support that a functional TSHR is expressed in chondrocytes. Figure 3D shows the effect of TSH on gene expression of TSHR, Sox-9, and type IIa collagen in primary cultured chondrocytes (14) . Addition of 1 mU/ml TSH decreased TSHR mRNA levels to 73 Ϯ 10% of that of the cells cultured without TSH (P Ͻ 0.01). TSH also significantly decreased Sox-9 and type IIa collagen mRNA levels in chondrocytes, suggesting that TSH might induce chondrocytes to a dedifferentiated state.
Studies of the roles of TSH/TSHR on skeletal development of mice in vivo.
To determine the importance of TSH/TSHR in the development of mice, we compared the growth of two distinct mouse models of hypothyroidism. These models differed in that the normal reciprocal relationship between thyroid hormone and TSH was intact in one and disrupted in the other. One model, THYx mice (n ϭ 6), had a 110-fold increase in TSH, with low serum free T 4 and a normal TSHR; in contrast, the other model, hyt/hyt mice (n ϭ 5), had a 135-fold elevation of TSH with low serum free T 4 but a nonfunctional TSHR (Fig. 4A) . As controls, wild-type mice (n ϭ 6) and hyt/hyt mice given oral thyroid hormone supplements (hyt/hyt ϩ TH, n ϭ 6) were employed. Sham operation was carried out in wild-type, hyt/hyt, and hyt/hyt ϩ TH mice at 21 days after birth. Serum GH levels of THYx and hyt/hyt mice at the end of experiment (39 days old) were significantly lower than that of wild-type of mice (P Ͻ 0.001) but levels of which in THYx and hyt/hyt mice were almost equal (Fig. 4B) . No significant difference in serum Ca 2ϩ levels was observed in these four groups of mice (Fig. 4C) .
At the start of the experiment (25 days after birth), wild-type and THYx mice were significantly taller than hyt/hyt mice. During the experiment, hyt/hyt mice grew faster than THYx mice, and hyt/hyt ϩ TH mice also grew faster than wild-type mice. Actual increases in length of these four groups of mice over 2 wk are shown in Fig. 4D . The increase in length at the end of experiment (39 days old) was significantly larger in hyt/hyt mice (7.2 Ϯ 0.82 mm) than in THYx mice (2.1 Ϯ 0.02 mm, P Ͻ 0.01). Interestingly, the increase in length was significantly larger in hyt/hyt ϩ TH mice (16.9 Ϯ 1.5 mm) than in wild-type mice (12.4 Ϯ 1.2 mm, P Ͻ 0.01). Figure 5 , A and B, shows the length of the left tibia from four groups of mice at the end of the experiment. The tibia was significantly longer in hyt/hyt mice (n ϭ 5) than that in THYx mice (n ϭ 6, P Ͻ 0.05). The tibia tended to be longer in hyt/hyt ϩ TH mice than in wild-type mice, but this difference did not reach the level of statistical significance. Microscopic features of epiphysial cartilage from the THYx (n ϭ 6), hyt/hyt (n ϭ 5), hyt/hyt ϩ TH, (n ϭ 6), and wild-type mice (n ϭ 6) are shown in Fig. 5C . Proliferative (PZ) and hypertrophic zones (HZ) of THYx mice were very atrophic, and epiphysial cartilage was narrower in THYx mice than in hyt/hyt mice (P Ͻ 0.01). PZ ϩ HZ was wider in hyt/hyt ϩ TH mice than in wild-type mice (Fig. 5D) .
We compared levels of Sox-9 and type IIa collagen transcripts in the epiphysial cartilage of the right tibia from THYx mice (n ϭ 6) and hyt/hyt mice (n ϭ 5). The level of each transcript in the tissue from hyt/hyt mice was normalized to GAPDH and set as 1.0 for each transcript; Sox-9 and type IIa collagen transcripts in the cartilages from THYx mice were 0.43 Ϯ 0.05 and 0.22 Ϯ 0.06, respectively (Fig. 5E) .
DISCUSSION
Mice harboring a TR␣ mutation or deletion though their TSH and free T 4 are almost in the normal range and display delayed endochondral ossification (19, 31) . Furthermore, 
TR␣
PV/wild heterozygous mice are 40% shorter than wild-type littermates (17) . Very recently, Bochukova et al. (9) reported a 6-yr-old girl harboring a TR␣1 mutation. She had a growth deficit in the lower segment of the body, where femoral epiphysial dysgenesis and retarded bone age were observed. In the present study, hyt/hyt mice supplemented with TH also grew faster than nonsupplemented hyt/hyt mice (Fig. 4D) . Thus, there is no doubt that deficiency of thyroid hormones plays a central role in the pathogenesis of growth retardation in cretinism. In contrast, growth delay of hyt/hyt mice was much milder than that in THYx mice or TR PV/wild mice. In the THYx mice model, the possibility might arise that all parathyroid glands were removed, which induced hypocalcemia and affected skeletal development. However, no significant difference in serum Ca 2ϩ levels was observed between the THYx and the wild-type mice. Therefore, it is likely that some parathyroid glands remained in our THYx mice. These results suggest that high TSH is also involved in the pathogenesis of epiphysial dysgenesis in hypothyroidism.
In 2008, Marino et al. (20) proposed the idea that growth inhibition due to hypothyroidism slows the developmental program of growth plate senescence (aging), including the normal decline in the rate of longitudinal bone growth. The hyt/hyt mice have congenital hypothyroidism with onset before birth, whereas THYx mice have acquired hypothyroidism. Therefore, in this context it is possible to interpret that faster growth of the untreated hyt/hyt mice compared with THYx mice is due to delayed growth plate senescence. At present, mechanisms of delayed growth plate senescence in hypothyroidism remain unknown, so further elucidations will be needed to clarify the roles of TSH/TSHR in growth plate senescence observed in hypothyroidsm.
In contrast, the effects of TSH on bone have been extensively studied. We first reported the expression of TSHR in osteoblast-like rat osteosarcoma cells (16) . In 2003, Abe et al.
(1) developed TSHR knockout mice and found that osteoblasts and osteoclasts express the TSHR, and TSHR-null mice treated with thyroid extract had a phenotype of high bone turnover osteoporosis at 6 -7 wk of age. Subsequently, Hase et al. (13) revealed that TSH negatively regulates osteoclast differentiation by inhibiting TNF␣ production. Sun et al. (30) reported that intermittent injection of recombinant TSH to rats displayed a powerful antiresorptive action on bone in vivo. Sampath et al. (26) also found that administration of low-dose TSH to aged ovarectomized rats restores bone volume. Moreover, by comparing the skeletal phenotypes of wild-type and Tshr knockout mice that were rendered hyperthyroid, Baliram et al. (3) conclusively demonstrated the dual actions of thyroid hormones and TSH on bone. All these data support the hypothesis that TSH signaling contributes to bone formation. However, some reported that primary cultured osteoblasts expressed TSHR, but TSH elicited no cAMP response. By comparing bone phenotypes between hyt/hyt mice and Pax8 Ϫ/Ϫ mice, they claimed that lack of thyroid hormones rather than excess TSH caused delayed ossification, a trabecular bone remodeling defect, and reduced bone mineralization (6) . To examine whether low TSH results in osteoporosis in the human, several groups determined bone mineral density (BMD) in patients with isolated TSH deficiency (ITSHD). Iida et al. (15) reported that BMD of a patient with ITSHD (56-yr-old woman) was markedly diminished, with a value of Ϫ4.8 standard deviations, compared with a young adult's mean. However, Papadimitriou et al. (24) reported that chronic extremely low TSH levels in children with ITSHD, in the face of normal thyroid hormone levels, are not related to osteoporosis.
Apart from the role of the TSH/TSHR in osteoblast or osteoclast functions, the role of the TSH/TSHR in the pathogenesis of epiphysial dysgenesis in hypothyroidism remains unknown. The present study demonstrated that chondrocytes expressed a functional TSHR at levels comparable to that seen in the thyroid and that TSH suppressed the chondrocyte differentiation marker genes in epiphysial chondrocytes. Al- 125 I-TSH binding activity was measured by the protocol of Mizutori (22) . Cellular cAMP after addition of TSH was assayed using a commercially available RIA kit. D: Levels of TSHR, Sox-9, and type IIa collagen (Col 2a) mRNAs were measured in primary cultured chondrocytes before (filled bars) and 24 h after addition of 100 U/ml (gray bars) and 1 mU/ml (open bars) of bovine TSH (Sigma-Aldrich Chemical). Target gene mRNA/18S RNA in the cells before addition of TSH was set as 1.0, and relative expression is shown. Data are expressed as means Ϯ SE of 3 independent experiments. *P Ͻ 0.01. though serum GH levels are low in both THYx and hyt/hyt mice, epiphysial dysgenesis in the former is more severe than in the latter, suggesting that epiphysial dysgenesis was a direct effect of TSH on epiphysial chondrocytes.
Usually, patients with hypothyroidism are treated with oral administration of thyroid extracts or T 4 , which, in turn, decreases serum TSH levels in a physiological negative feedback loop. Our present data suggest the dual actions of thyroid hormones and TSH on growth plate chondrocyts, so we speculate that low T 4 causes abnormal skeletal development in young children with hypothyroidism, but high serum TSH also contributes to the growth retardation seen in these affected individuals.
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